Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Neither retatrutide nor cagrilintide is currently FDA-approved
This initial dose allows the body to adjust to GLP-1 and GIP receptor activation
Pratley, MD, Medical Director at the AdventHealth Diabetes Institute Orlando, FL, and Co-Chair of the FLOW Trial
For a deeper look at pricing, dosage options, and where to buy it safely, read our complete guide to compounded tirzepatide in Nigeria
Dosing typically starts low and is gradually increased over time to help minimize side effects while maximizing effectiveness
[78] In any case, the quality of evidence for both treatments is very low and it is unclear whether either is definitely effective
